GGrantIndex
Sort

261,768 grants matching gene therapy

Role of Innate Immune System in Pathogen Induced Chronic Inflammation

$1,498,183
Caroline A Genco · Boston University Medical Campus · P01 · FY2013 · AI

Gene Therapy that Systemically Produces Brain-penetrating Replacement Enzyme for MPS IIIA (Sanfilippo A Syndrome)

$1,498,067
Shivakumar Devaiah Pattada · Biostrategies, Lc · R44 · FY2024 · NS

Retinal Ganglion Cell Replacement in Optic Neuropathies

$1,498,013
Jeffrey L Goldberg · Stanford University · U24 · FY2018 · EY

Mechanisms of Esophageal Carcinogenesis

$1,497,773
Anil K Rustgi · University Of Pennsylvania · P01 · FY2006 · CA

Human Artificial Chromosomes for Cancer Research and Functional Genomics

$1,497,695
Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer

$1,497,616
Howard C Crawford · University Of Michigan At Ann Arbor · U01 · FY2017 · CA

Genetically-engineered pig organ transplantation in baboons: immunological and functional studies

$1,497,591
David Kc Cooper · University Of Alabama At Birmingham · U19 · FY2020 · AI

Genetically-engineered pig organ transplantation in baboons: immunological and functional studies

$1,497,588
David Kc Cooper · University Of Alabama At Birmingham · U19 · FY2021 · AI

Sex Differences in Cardiometabolic Health and Disease

$1,497,580
Karen Reue · University Of California Los Angeles · U54 · FY2023 · HL

From therapeutic mechanisms to unraveling the pathophysiology of MS

$1,497,510
Bibiana Bielekova · National Institute Of Neurological Disorders And Stroke · ZIA · FY2013 · NS

Bio-Therapies for the Treatment of Cancer

$1,497,348
David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Wellstone Muscular Dystrophy Specialized Research Center (Seattle)

$1,497,307
Jeffrey S Chamberlain · University Of Washington · P50 · FY2018 · AR

Identification of Genes Involved in Major Mood Disorders

$1,497,299
Francis J McMahon · National Institute Of Mental Health · ZIA · FY2016 · MH

Targeted Therapy in Neuroendocrine Cancer

$1,497,249
Samira Sadowski · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial

$1,497,170
Michael E Wechsler · National Jewish Health · U01 · FY2014 · AI

Sex Differences in Cardiometabolic Health and Disease

$1,497,077
Karen Reue · University Of California Los Angeles · U54 · FY2025 · HL

Gene Therapy for Inherited Blood Disorders

$1,497,052
Andre Larochelle · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

GENE THERAPY APPROACHES FOR BLOOD AND VASCULAR DISEASES

$1,496,835
City Of Hope/Beckman Research Institute · P01 · FY2004 · HL

improving outcomes after stem cell transplantation

$1,496,532
Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL

RAGE and Mechanisms of Vascular Dysfunction

$1,496,524
Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2017 · HL

Integrative proteogenomics for elucidation of tumor-specific cell surface proteomes in ultra-rare cancers

$1,496,492
Alex Kentsis · Sloan-Kettering Inst Can Research · U01 · FY2024 · FD

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

$1,496,347
Daniel Woo · University Of Cincinnati · U01 · FY2016 · NS

Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)

$1,496,118
Charles Andrew Stewart · Cartesian Therapeutics, Inc. · R44 · FY2025 · NS

Manufacturing RNA-based CAR T cells to combat autoantibody-associated autoimmune disorders (AAAD)

$1,496,118
Christopher M Jewell · Cartesian Therapeutics, Inc. · R44 · FY2024 · NS

Lambda Genetic Networks and Lambda Red-Mediated Recombination

$1,495,905
Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA